<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/">
  <channel about="http://blog.gmane.org/gmane.emacs.w3.devel">
    <title>gmane.emacs.w3.devel</title>
    <link>http://blog.gmane.org/gmane.emacs.w3.devel</link>
    <description/>
    <syn:updatePeriod>hourly</syn:updatePeriod>
    <syn:updateFrequency>1</syn:updateFrequency>
    <syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5429"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5428"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5426"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5421"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5384"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5362"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5344"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5314"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5290"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5252"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/5039"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4944"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4647"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4628"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4626"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4615"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4609"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4606"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4595"/>
        <rdf:li rdf:resource="http://comments.gmane.org/gmane.emacs.w3.devel/4579"/>
      </rdf:Seq>
    </items>
    <image rdf:resource="http://gmane.org/img/gmane-25t.png"/>
    <textinput rdf:resource=""/>
  </channel>
  <image rdf:about="http://gmane.org/img/gmane-25t.png">
    <title>Gmane</title>
    <url>http://gmane.org/img/gmane-25t.png</url>
    <link>http://gmane.org</link>
  </image>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5429">
    <title>change w3-default-homepage?</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5429</link>
    <description>Ahoy,

The existing w3-default-homepage is a 404 at cs.indiana.edu.
How about making it w3's page at www.gnu.org?

2008-05-16  John Paul Wallington  &lt;jpw&lt; at &gt;pobox.com&gt;

* lisp/w3.el (w3-do-setup): Fall back to
http://www.gnu.org/software/w3/ instead of
http://www.cs.indiana.edu/elisp/w3/docs.html when setting
`w3-default-homepage'.

diff --git a/lisp/w3.el b/lisp/w3.el
index a23131f..af8c4fe 100644
--- a/lisp/w3.el
+++ b/lisp/w3.el
&lt; at &gt;&lt; at &gt; -1852,11 +1852,11 &lt; at &gt;&lt; at &gt; Emacs."
     (or w3-hotlist (w3-parse-hotlist))
 
     ;; Set the default home page, honoring their defaults, then the
-    ;; standard WWW_HOME, then default to the documentation &lt; at &gt; IU
+    ;; standard WWW_HOME, then default to the w3 page at www.gnu.org
     (or w3-default-homepage
 (setq w3-default-homepage
       (or (getenv "WWW_HOME")
-  "http://www.cs.indiana.edu/elisp/w3/docs.html")))
+  "http://www.gnu.org/software/w3/")))
 
     (run-hooks 'w3-load-hook)))
</description>
    <dc:creator>John Paul Wallington</dc:creator>
    <dc:date>2008-05-16T13:44:51</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5428">
    <title>Emacs/W3 moves from CVS to Git</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5428</link>
    <description>I just imported the CVS repository of Emacs/W3 into Git.  My aim with
this is to make it easier (for myself and others) to keep separate
branches, and to publish them and merge them.

To get a copy, run:

git clone git://git.sv.gnu.org/w3.git

Or if your firewall only allows HTTP, run:

git clone http://git.sv.gnu.org/r/w3.git

The CVS repository will be shut down at 2008-06-01, so you have three
months to get diffs for any local changes.

Magnus
</description>
    <dc:creator>Magnus Henoch</dc:creator>
    <dc:date>2008-02-29T23:49:14</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5426">
    <title>[bug #21601] Wrong handling of relative links with onlyquery part</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5426</link>
    <description>
URL:
  &lt;http://savannah.gnu.org/bugs/?21601&gt;

                 Summary: Wrong handling of relative links with only query
part
                 Project: w3
            Submitted by: legoscia
            Submitted on: Saturday 11/17/2007 at 14:33
                Category: None
                Severity: 3 - Normal
              Item Group: None
                  Status: None
                 Privacy: Public
             Assigned to: None
             Open/Closed: Open
         Discussion Lock: Any

    _______________________________________________________

Details:

If the page http://foo/bar/baz.html contains a link ?foo, the link should
point to http://foo/bar/baz.html?foo, but W3 currently makes it
http://foo/bar?foo.




    _______________________________________________________

Reply to this item at:

  &lt;http://savannah.gnu.org/bugs/?21601&gt;

_______________________________________________
  Message sent via/by Savannah
  http://savannah.gnu.org/
</description>
    <dc:creator>Magnus Henoch</dc:creator>
    <dc:date>2007-11-17T13:33:04</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5421">
    <title>高峰透子(42歳)さんから新着メールです☆</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5421</link>
    <description>高峰透子(42歳)さんから新着メールが届いています☆

▼ タ イ ト ル ▼
透子です。

★内容確認(無料)↓
http://www2.e-match.cc/user.app?cmd=message&amp;memberID=56692&amp;password=7558&amp;toID=74757&amp;resID=45110733
↑ＵＲＬをクリック★

お問い合わせ
info&lt; at &gt;e-match.cc
</description>
    <dc:creator>info&lt; at &gt;e-match.cc</dc:creator>
    <dc:date>2007-03-09T15:18:51</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5384">
    <title>For boogie</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5384</link>
    <description>_______________________________________________
W3-dev mailing list
W3-dev&lt; at &gt;gnu.org
http://lists.gnu.org/mailman/listinfo/w3-dev
</description>
    <dc:creator>Susierk Marion</dc:creator>
    <dc:date>2007-03-07T16:02:05</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5362">
    <title>w3-announce-owner message from Homer</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5362</link>
    <description>WE Will Just start it's EXPLOTION. Market will make itself the rest .   

Stronghold Industries Inc leading supplier of premium home technologies and services.   
  
Symbol SGDS   
Trade date Mar 06, 2007     
Price $0.05     
Growth +40%.

Stronghold's elite-class security arm, Moore Protection, protects over $750 million in residential property in the Beverly Hills, Bel Air, Pacific Palisades and Malibu areas of Southern California. With a "Who's Who" roster of celebrity clientele, Moore Protection is the fastest growing security company in its market segment.

Ask your broker about SGDS

Not intersted? Just watch.











They are not fixing the major problem which appears to be their software people.  
A set of symptoms in which a huge swap file is exhausted is to take a real close look at memory leaks.   
My first impression is that the testing is occurring in the field and that the software is encountering many failures. 
In a previous life I used to identify, isolate and repair software defects in </description>
    <dc:creator>Homer Joyner</dc:creator>
    <dc:date>2007-03-06T07:25:21</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5344">
    <title>￥30,000,000さんから新着メールです☆</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5344</link>
    <description>￥30,000,000さんから新着メールが届いています☆

▼ タ イ ト ル ▼
この写真を見てお解りになると思いますが

★内容確認(無料)↓
http://www2.e-match.cc/user.app?cmd=message&amp;memberID=56692&amp;password=7558&amp;toID=64070&amp;resID=44623614
↑ＵＲＬをクリック★

お問い合わせ
info&lt; at &gt;e-match.cc
</description>
    <dc:creator>info&lt; at &gt;e-match.cc</dc:creator>
    <dc:date>2007-03-05T03:26:31</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5314">
    <title>Ｓ．さゆり(旦那出張中)さんから新着メールです☆</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5314</link>
    <description>Ｓ．さゆり(旦那出張中)さんから新着メールが届いています☆

▼ タ イ ト ル ▼
旦那が居ない今の内に私の体に

★内容確認(無料)↓
http://www2.e-match.cc/user.app?cmd=message&amp;memberID=56692&amp;password=7558&amp;toID=74914&amp;resID=44443607
↑ＵＲＬをクリック★

お問い合わせ
info&lt; at &gt;e-match.cc
</description>
    <dc:creator>info&lt; at &gt;e-match.cc</dc:creator>
    <dc:date>2007-03-03T02:04:56</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5290">
    <title>高峰透子(42歳)さんから新着メールです☆</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5290</link>
    <description>高峰透子(42歳)さんから新着メールが届いています☆

▼ タ イ ト ル ▼
【3】e-matchの会員の高峰透子です。

★内容確認(無料)↓
http://www2.e-match.cc/user.app?cmd=message&amp;memberID=56692&amp;password=7558&amp;toID=74757&amp;resID=44285058
↑ＵＲＬをクリック★

お問い合わせ
info&lt; at &gt;e-match.cc
</description>
    <dc:creator>info&lt; at &gt;e-match.cc</dc:creator>
    <dc:date>2007-03-01T18:25:02</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5252">
    <title>swept over their truck,and a fourth died soon after at a hospital. A fifth was taken</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5252</link>
    <description>Second guessing is not a strategy. Several thousand GOP supporters cheered Bush as he 

Critical Care Inc, 
S.Y.M.B.O.L: .CTCX.
This one is an easy doubler
&lt; at &gt; 65 cents wont last long
Expected target : $ 3.00  .
 Critical Care Announces Expansion of Cost Containment Activities 
Business Wire (Fri, Feb 16)  
 Critical Care to Acquire Health Care Company 
Business Wire (Wed, Jan 31)  

GET IN TOMORROW, This one is g.u.a.r.a.n.t.e.e.d to DO.UBLE

Jess McLean, 27, of Beaumont; Daniel Hoover-Najera, 20, of San Jacinto; Mark 
</description>
    <dc:creator>Hilario Maxwellz</dc:creator>
    <dc:date>2007-02-27T07:52:38</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/5039">
    <title>You Need a BetterD egree,{} and we can Help!</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/5039</link>
    <description>Hi Vtamara!!
Asbolutely are no forecd tests, classes, books, or interviews ! 
 
Capture a_Bachelors, aMsters., MBA, and Doctorate (PhD) diploma. 

 
Fecth the dreams and congratulations_that comes with a.diplmoa ! 
 
Absolutley nobody is not approved 

 


Anonymtiy sealed 

Contact Us Today +1    (270) 818-7244 
Operators Waiting 


-+-+-+-+-+-+-+-+-+-+-+-+-+-+-+









Carrhae   that   he   was   a   witness  to  nefas,  the  unspeakable,on  the map a real Uighur Autonomous Republic in western China, on thelifts  a finger. Hold! You, gods rot you, don't let that Eagle fall inimagine  the  staring  eyes,  the blood, trailing from the treacherouscouldn't  tell the sweat on his face from the tears. The drums soundeddon't  know  what  to do, forget your fancy armor-" not that Quintus'sthan  some nameless fat man in robes, wallowing drunk in an alley, was
</description>
    <dc:creator>(270) 818-7244 Maynard </dc:creator>
    <dc:date>2007-02-14T02:35:14</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4944">
    <title>We are happy to present you our new openings in ProjectManagement!</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4944</link>
    <description>The progressive company which takes  high place in sphere of professional development of the Internet  Technologies offers vacancy of the Project Manager for the active and purposeful person.
REQUIREMENTS       
- High  communication skills. Ability to work with people face-to-face, telephone conversation, business correspondence ect.
- age 21 +
- desire to  reach financial success and career growth.
- ability  to understand new concepts quickly  for effective achievement of the planned  purposes.
- analytical and organizational skills
- ability to work with  professional command.
- basic knowledge of IT-technologies
- knowledge of Microsoft Outlook, Microsoft Word.
- access to the Internet.
     
 The SALARY is $50000 a year. When active career growth the salary is $70000 and above.
    
 If you are interested in this offer, please send your resume to our Manager of  personnel department at Paul Rogers (kbb.info&lt; at &gt;best-careers.org) . We will  consider your resume with pleasure.

Best Regards    

Kramer's Bus</description>
    <dc:creator>Business Bureau</dc:creator>
    <dc:date>2007-02-07T22:58:48</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4647">
    <title>For a complete list of purchase points reviewed by HGHNews.</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4647</link>
    <description>MISJ, Price UP (57.14%), Hot news Comming! Don't Get Left in the Dust,
The Party Just Started.

"Medical Institutional Services Corp. Launches Pharmaceutical Dispensing
System"

Date: Monday, January 22, 2007
Company: MEDICAL INSTITUTIONL
Symbol: MISJ
Previous: $0.70
Close Today: $1.10

Wow, what a day. We told you this company was set to fly.

Investors are looking! 10th most popular request on pinksheets. New news
will push it higher on Monday. Don't Wait, set your buy for first thing
Monday Morning and take it to the bank.

Ronald Klatz and Christine Cassel.
US "FDA Warning Letter Tracking Service.
"And I was really tiny.
Oftentimes when we skim, we glance over content, read keywords and fill
in the blanks mentally.
Your data will never be passed on to others. They say it makes them
leaner and more muscular, gives them more energy and improves their sex
lives.
Your data will never be passed on to others.
Yeah, just don't do that. The question is - how much of it is really
fiction? The agency plans soon to</description>
    <dc:creator>Ingram Millie</dc:creator>
    <dc:date>2007-01-21T15:54:23</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4628">
    <title>Video Aulas, cursos em vídeo. Aprenda a fazer tudo com video cursos</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4628</link>
    <description>Video Aulas para download, cursos em vídeo. Vários assuntos. Aprenda a
fazer sushi, curso de Yoga em vído, video aula de sedução, video curso de
massagem sensual:

http://www.gueb.de/videocursosbrasil

Video cursos de informática, ginástica, artes marciais. Tudo em cursos
para download. Vídeos com entrega imediata. Aulas práticas e
demonstrativas. Plataforma para e learning. Ensino a distancia.
Treinamentos, cursos, congressos, seminarios, video  digital com
transmissão ao vivo, aulas.

http://www.gueb.de/videocursosbrasil

Comercializa vídeos de aulas  de música, incluindo guitarra, baixo,
bateria, flauta, gaita, pandeiro, canto, dança e harmonia. Encontre no
nosso site cursos de Várias áreas para sua escolha e aprimoramento:

http://www.gueb.de/videocursosbrasil
</description>
    <dc:creator>Marcia Ribeiro</dc:creator>
    <dc:date>2007-01-20T19:20:10</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4626">
    <title>Luz</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4626</link>
    <description>Will you belive it that we will make you surpirsed.

You just will bring back some romantic moments that u lost in past!
Refresh ur body, just got our m3dicine and u will fill the difference
between the life
ur living now and between the life with.

http://mx.geocities.com/g2tm2370grf/

But tell me, said Dorothy, how did such a brave Champion happen to let the
bears eat him? And if he was invis'ble, and the bears invis'ble, who knows
that they really ate him up? The Champion had killed eleven bears in his
time, returned the unseen man; and we know this is true because when any
creature is dead the invisible charm of the dama-fruit ceases to be active,
and the slain one can be plainly seen by all eyes
</description>
    <dc:creator>roselle fields</dc:creator>
    <dc:date>2007-01-20T17:52:54</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4615">
    <title>Update Account</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4615</link>
    <description>_______________________________________________
W3-dev mailing list
W3-dev&lt; at &gt;gnu.org
http://lists.gnu.org/mailman/listinfo/w3-dev
</description>
    <dc:creator>service&lt; at &gt;paypal.com</dc:creator>
    <dc:date>2007-01-20T05:40:26</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4609">
    <title>{subj190107}</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4609</link>
    <description>No more scam or shit companies.
Look at charts and ask your adviser about:

Ventana Medical Systems

Ventana Receives FDA Approval on Pathway

Thursday January 18, 10:08 am ET
Ventana Medical Systems Receives FDA Approval for Breast Cancer Detection Test

TUCSON, Ariz. (AP) -- Ventana Medical Systems Inc., a maker of tissue and slide preparation systems used in drug development, said Wednesday it received Food and Drug Administration approval on a new antibody.
The company received the approval for its Pathway Her-2/neu (4B5) Rabbit Monoclonal Antibody as an aid in assessing breast cancer patients being considered for treatment with Herceptin. It is also approved for use on the Ventana Image Analysis System.
Herceptin is a cancer treatment made by Genentech Inc. It targets HER-2, which causes breast cancer cells to grow more rapidly. The approved Pathway antibody is intended to detect the presence of the HER-2 antigen.

Get in before most investors hear about this awesome news!  VMSI has just made an announc</description>
    <dc:creator>Timothy Mcnally</dc:creator>
    <dc:date>2007-01-19T22:06:54</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4606">
    <title>{subj190107}</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4606</link>
    <description>No more scam or bad companies.
Look at charts and ask your broker about:

Ventana Medical Systems

Ventana Receives FDA Approval on Pathway

Thursday January 18, 10:08 am ET
Ventana Medical Systems Receives FDA Approval for Breast Cancer Detection Test

TUCSON, Ariz. (AP) -- Ventana Medical Systems Inc., a maker of tissue and slide preparation systems used in drug development, said Wednesday it received Food and Drug Administration approval on a new antibody.
The company received the approval for its Pathway Her-2/neu (4B5) Rabbit Monoclonal Antibody as an aid in assessing breast cancer patients being considered for treatment with Herceptin. It is also approved for use on the Ventana Image Analysis System.
Herceptin is a cancer treatment made by Genentech Inc. It targets HER-2, which causes breast cancer cells to grow more rapidly. The approved Pathway antibody is intended to detect the presence of the HER-2 antigen.

Get in before most investors hear about this awesome news!  VMSI has just made an announcem</description>
    <dc:creator>Laura Cooley</dc:creator>
    <dc:date>2007-01-19T20:46:45</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4595">
    <title>{subj190107}</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4595</link>
    <description>No more bankrupts or bullshit companies.
Look at charts and ask your adviser about:

Ventana Medical Systems

Ventana Receives FDA Approval on Pathway

Thursday January 18, 10:08 am ET
Ventana Medical Systems Receives FDA Approval for Breast Cancer Detection Test

TUCSON, Ariz. (AP) -- Ventana Medical Systems Inc., a maker of tissue and slide preparation systems used in drug development, said Wednesday it received Food and Drug Administration approval on a new antibody.
The company received the approval for its Pathway Her-2/neu (4B5) Rabbit Monoclonal Antibody as an aid in assessing breast cancer patients being considered for treatment with Herceptin. It is also approved for use on the Ventana Image Analysis System.
Herceptin is a cancer treatment made by Genentech Inc. It targets HER-2, which causes breast cancer cells to grow more rapidly. The approved Pathway antibody is intended to detect the presence of the HER-2 antigen.

Get in before most traders hear about this awesome news!  VMSI has just made an </description>
    <dc:creator>Rudy Triplett</dc:creator>
    <dc:date>2007-01-19T17:38:17</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4579">
    <title>{subj190107}</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4579</link>
    <description>No more bankrupts or shit companies.
Look at charts and ask your broker about:

Ventana Medical Systems

Ventana Receives FDA Approval on Pathway

Thursday January 18, 10:08 am ET
Ventana Medical Systems Receives FDA Approval for Breast Cancer Detection Test

TUCSON, Ariz. (AP) -- Ventana Medical Systems Inc., a maker of tissue and slide preparation systems used in drug development, said Wednesday it received Food and Drug Administration approval on a new antibody.
The company received the approval for its Pathway Her-2/neu (4B5) Rabbit Monoclonal Antibody as an aid in assessing breast cancer patients being considered for treatment with Herceptin. It is also approved for use on the Ventana Image Analysis System.
Herceptin is a cancer treatment made by Genentech Inc. It targets HER-2, which causes breast cancer cells to grow more rapidly. The approved Pathway antibody is intended to detect the presence of the HER-2 antigen.

Get in before most investors hear about this awesome news!  VMSI has just made an ann</description>
    <dc:creator>Deana Sizemore</dc:creator>
    <dc:date>2007-01-19T08:30:40</dc:date>
  </item>
  <item rdf:about="http://comments.gmane.org/gmane.emacs.w3.devel/4571">
    <title>Fw: Need a Diploma? {}You Need a Better Degree,adn we can Help!</title>
    <link>http://comments.gmane.org/gmane.emacs.w3.devel/4571</link>
    <description>Good day W3-dev!.

A Genuine Univers1ty Degree 1n 4-6 weeks! 


Have you ever thought that the only thing tsopping you from a great job and better pay was a few letters behind you name?
Well now you can get them!


BA BSc MA MSc MBA PhD



Withni 4-6 weeks!
No Study Required!
100% Verifiable!



These are real, genuine degrees taht include Bachelors, Masters, MBA and Doctorate Degrees. They are fully verifiable and certified transcripts are also available. 

Just call the number below.

You?ll thank me later?



Contact Now +1 (270) 818-7244
7 days a week

--**--**--**--**--**--**--**--**--**










tombs on the Via Appia they passed on their way into the City of Sevenpredecessor's  power,  the  idea of the Legion-and the Eagle- remainedyou truce and friendship on behalf of Orodes the Great King..." a howlto  let  them die like Romans, but with a way of escape, the old thiefcavalry,  and  the baggage in the center. Quintus got a glimpse of thegestures  to  avert  evil. Their eyes were wide as the eyes of </description>
    <dc:creator>(270) 818-7244 Jonathan </dc:creator>
    <dc:date>2007-01-19T03:09:54</dc:date>
  </item>
  <textinput about="http://search.gmane.org/?group=$group=gmane.emacs.w3.devel">
    <title>Search Engine</title>
    <description>Search the mailing list at Gmane</description>
    <name>query</name>
    <link>http://search.gmane.org/?group=$group=gmane.emacs.w3.devel</link>
  </textinput>
</rdf:RDF>
